Ustekinumab dose intensification after loss of response in CD does not improve steroid-free remission at 48 weeks compared with standard dosing.

Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma Recommendation based on positive results demonstrating ...

Alteogen Inc. (KOSDAQ: 196170) announced today that it has entered into an exclusive license agreement with Biogen Inc. for the development and commercialization of subcutaneous (SC) formulations of ...

Evan Coleman is an Updates Editor on the Credit Cards and Travel Rewards team at Forbes Advisor, showcasing his interest in personal finance and love of travel. He has written for a variety of local ...

How much fluid is too much in a “healthy” dog or cat under anesthesia? In this video interview with dvm360 during the 2026 ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...

Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. If you're finding your grocery bills are higher than you'd like, you might want to consider having a ...

Want more charts like these? See our charts on the secrets of the jobless recovery, the richest 1 percent of Americans, and how the superwealthy beat the IRS. How Rich Are the Superrich? A huge share ...